This was the stock's third consecutive day of gains.

Aurora Cannabis Inc. closed 36.67% below its 52-week high of $7.20, which the company achieved on August 15th.

Aurora Cannabis sees record Q4-2025 revenues driven by international sales, but low profits and weak 2026 outlook keep stock under pressure.

Canadian LPs offer better balance sheets and global potential vs. U.S. MSOs in cannabis investing. Find out why fundamentals ...

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S. ...

Researchers say the health-care system needs to be more aware of cannabis hyperemesis syndrome, a condition characterized by ...

Aurora posted a 619% jump in adjusted EBITDA, reaching CA 16.7 million in Q4 2025. Global medical cannabis net revenue surged 48% to CA 67.8 million, making up 75% of total net revenue. Get daily ...

Aurora Cannabis Inc (TSX:ACB) is set to release its Q4 2025 earnings on June 18, 2025. The consensus estimate for Q4 2025 revenue is $88.82 million, and the earnings are expected to come in at $0.11 ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing ...

Welcome to Aurora Cannabis Inc. Fiscal Fourth Quarter 2025 Results Conference Call. [Operator Instructions] The conference is being recorded today, Wednesday, June 18, 2025. I would […] ...

Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders PR Newswire Jul 9, 2025, 11:30:00 AM ...